The trajectory of Viagra, originally marketed by copyright, presents a complex case study for stakeholders considering the drug arena . Despite its initial success and impact of countless in sales, the intellectual property lapse has opened the way for generic medications, substantially reducing profit potential . This shift raises doubts about the